New drug combo shows promise for leg artery disease
NCT ID NCT07600385
First seen May 21, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study tested whether adding cilostazol to the standard statin drug rosuvastatin helps people with chronic leg artery disease (peripheral artery disease) feel better and walk farther. About 260 adults with stable leg symptoms for at least 6 months took either the combo or rosuvastatin alone for 24 weeks. The main goal was to see if the combo improved quality of life and reduced leg pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yonsei University College of Medicine, Severance Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.